关于加纳抗生素耐药性基因的系统审查和元分析
Eric S Donkor1, Alex Odoom2, Abdul-Halim Osman2
1Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, P. O. Box KB 4236, Accra, Ghana. esampane-donkor@ug.edu.gh.
BMC medical genomics
|March 13, 2025
概括
抗微生物耐药性基因在加纳的人类,动物和环境来源中共享. 这突显了耐药性的相互联系,以及需要采取多学科方法来打击抗菌素耐药性 (AMR).
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 抗生素耐药性 (AMR) 是一个重要的全球健康挑战,因为对抗生素耐药性基因 (ARG) 和其传播的理解有限.
- 调查加纳的ARG对于解决当地和全球AMR问题至关重要.
研究的目的:
- 系统地审查和对来自加纳的人类,动物和环境来源的细菌中ARG的流行情况进行元分析.
- 量化和估计特定ARG的流通情况.
主要方法:
- 在Web of Science,PubMed和Scopus数据库中的系统文献搜索,截至2024年2月25日.
- 使用纽卡斯尔-太华尺度 (NOS) 评估偏差风险.
- 描述性统计和数据解释的比例元分析.
主要成果:
- 38项研究符合纳入标准,涵盖了加纳的地理位置.
- 在ESBL基因的发病率: blaCTX-M (31.6%), blaTEM (19.5%), blaSHV (3.5%).
- 碳烯酶基因的发病率: blaNDM (17.2%),blaOXA (10.3%). 这两种基因的发病率都很高. 其他ARG如sul1,qnrS,gyrA,erm(B) 和mecA也被检测到.
结论:
- 来自加纳的人类,动物和环境来源的细菌共享ARG,表明相互联系.
- 横向基因转移促进ARG传播,强调需要一个健康的方法.
- 为了在加纳有效制抗药耐药性,一个多学科的战略是必不可少的.
关键词:
抗生素耐药性基因 (ARG) 是指抗生素耐药性的基因.抗微生物耐药性 (AMR) 是一种这里是加拿大加拿大加拿大加拿大.多种药物耐药性 (MDR)一个健康,一个健康.流行程度 流行程度系统性审查 系统性审查更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
240
06:54Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
930
相关概念视频
Antibiotic Selection
52.1K
Overview
52.1K
Genomic DNA in Prokaryotes
43.3K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
43.3K
Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K
